<DOC>
	<DOCNO>NCT02076945</DOCNO>
	<brief_summary>Background Between 25 55 % diabetic patient develop neuropathy secondary hyperglycemia . High resolution bedside ultrasound demonstrate useful tool detect presence neuropathy prior block performance , measure cross-sectional area posterior tibial nerve : value superior 19.01 mm2 distance 3 cm medial malleolus optimal threshold value identification diabetic sensorimotor polyneuropathy . Animal data show duration sciatic nerve block local anesthetic longer diabetic rat compare non-diabetic rat . Characteristics peripheral nerve blockade human diabetic sensorimotor neuropathy unknown . Aim The aim study compare duration analgesia characteristic ultrasound-guided popliteal sciatic nerve block diabetic patient neuropathy , diabetic patient without neuropathy non-diabetic patient without neuropathy , base ultrasound-measured cross-sectional area posterior tibial nerve . Hypothesis We hypothesize diabetic patient neuropathy duration analgesia last 50 % long patient without neuropathy . Methods This observational study diabetic non-diabetic patient , without peripheral neuropathy , base ultrasound-measured cross sectional area posterior tibial nerve 3 cm medial malleolus ( cut-off value , 19.01 mm2 ) All patient receive ultrasound-guided sciatic nerve block 30 mL1:1 mixture lidocaine 1 % bupivacaine 0.5 % , needle tip position bifurcation sciatic nerve peroneal tibial nerve , common fascia paraneurium . Block success confirm loss sensation pinprick distribution common peroneal tibial nerve 30 minute follow local anesthetic injection . This procedure complete saphenous nerve block . Postoperative pain management standardize . Pain block-related endpoint collect onset time action sensory motor blockade , duration analgesia , pain score opiates consumption among others . Relevance Defining duration analgesia case diabetic neuropathy help regional anesthesiologist well define type dos drug inject well prescribe postoperative multimodal analgesic treatment .</brief_summary>
	<brief_title>Characteristics Popliteal Sciatic Nerve Block Patients With Without Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>adult patient 1885 year old patient schedule undergo foot surgery Exclusion Criteria patient neuropathy cause genetic , metabolic inflammatory disease , well toxic agent drug ( eg chemotherapy agent ) ; patient chronic pain syndrome ; patient contraindication regional anesthesia ( e.g. , allergy local anesthetic ) ; chronic consumption opioids .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Regional anesthesia</keyword>
	<keyword>Diabetic neuropathy</keyword>
	<keyword>Ultrasound</keyword>
</DOC>